Pete Schmidt - Invivyd, Inc | 人才画像

基本信息

浏览量：0

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 10 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Safety, Pharmacokinetics, Serum Neutralizing Titers, and Immunogenicity of Adintrevimab, a Monoclonal Antibody Targeting SARS-CoV-2: A Randomized, Double-Blind, Placebo-Controlled, Phase 1 Dose-escalation Study in Healthy Adults

Pete Schmidt,Jean Gong,Kristin Narayan,Deepali Gupta,Frank Engler,Yong Li, Amanda Copans,Ed Campanaro

Infectious diseases and therapyno. 5 (2023): 1365-1377

引用3浏览0WOS引用

Prevention of COVID-19 Following a Single Intramuscular Administration of Adintrevimab: Results From a Phase 2/3 Randomized, Double-Blind, Placebo-Controlled Trial (EVADE)

Michael G Ison, Debra F Weinstein,Marta Dobryanska, Anna Holmes,Anne-Marie Phelan,Yong Li,Deepali Gupta,Kristin Narayan, Kazima Tosh,Ellie Hershberger,Lynn E Connolly,Ilker Yalcin,Ed Campanaro,Pamela Hawn,Pete Schmidt,

OPEN FORUM INFECTIOUS DISEASES（2023）

引用1浏览0WOS引用

Efficacy and Safety of Adintrevimab (ADG20) for the Treatment of High-Risk Ambulatory Patients With Mild or Moderate COVID-19: Results From a Phase 2/3, Randomized, Placebo-Controlled Trial (STAMP) Conducted During Delta Predominance and Early Emergence of Omicron

Michael G. Ison,Myra W Popejoy,Nikolay Evgeniev,M. Tzekova,Kathryn Mahoney,Natalia Betancourt,Yong Li,Deepali Gupta,Kristin Narayan,Ellie Hershberger,Lynn Connolly,Ilker Yalcin, Anita Das, J. R. Genge, M T D Smith,Ed Campanaro,Pamela Hawn,Pete Schmidt, Hiago Santos Soares Muniz,M. Tzekova, Kiril Palaveev, Vasil Tsenov, Liliya Pekova, Antoaneta Hadzhieva, Rumyana Mitreva, Nikolay Nikolaev, Elena Gyuzeleva, Marc Oliver Kornmann, Olaf Schmidt,Garyphalia Poulakou,Haralampos Milionis,Diamantis P. Kofteridis,Meletios Α. Dimopoulos, Ilias Skopelitis,Anastasia Kotanidou,Sotirios Tsiodras, Grzegorz Kania, Dagmara Grenik, Tomasz Zając,Anca Streinu‐Cercel,Larisha Pillay-Ramaya,Mohamed Mookadam,Lerato Mohapi, Johan Geldenhuys, Yacoob Vahed, C B S Bryce Holmgren, Martha Mekebeb-Reuter,William Brumskine, Daphne de Jong, Natasha Joseph, Kirsten McHarry, Shahid Wadvalla, Olena Kobrynska, I. V. Kireyev, Kyrylo Lebed, Pavlo Logoida, Ольга Василівна Барна,Olga Gyrina, Bogdan Gundertaylo, В. В. Родіонова

Open Forum Infectious Diseases (2023)

引用2浏览0引用

Efficacy and Safety of Adintrevimab (ADG20) for the Treatment of High-Risk Ambulatory Patients With Mild or Moderate Coronavirus Disease 2019: Results From a Phase 2/3, Randomized, Placebo-Controlled Trial (STAMP) Conducted During Delta Predominance and Early Emergence of Omicron

Michael G. Ison,Myra Popejoy,Nikolay Evgeniev,Maria Tzekova,Kathryn Mahoney,Natalia Betancourt,Yong Li,Deepali Gupta,Kristin Narayan,Ellie Hershberger,Lynn E. Connolly,Ilker Yalcin,Anita F. Das, John Genge,Michelle Smith,Ed Campanaro,Pamela Hawn,Pete Schmidt, Heloisa Costa Ravagnani Muniz

Open forum infectious diseasesno. 6 (2023)

引用2浏览0WOS引用

Antibody-mediated Protection Against Symptomatic COVID-19 Can Be Achieved at Low Serum Neutralizing Titers

Pete Schmidt,Kristin Narayan,Yong Li,Chengzi I. Kaku,Michael E. Brown,Elizabeth Champney,James C. Geoghegan,Maximiliano Vasquez,Eric M. Krauland,Thomas Yockachonis,Shuangyi Bai,Bronwyn M. Gunn, Anthony Cammarata, Christopher M. Rubino,Paul Ambrose,Laura M. Walker

SCIENCE TRANSLATIONAL MEDICINE（2023）

引用11浏览0引用

1363. Preliminary Safety Results from a Phase 1 First in Human Study of VYD222: an Extended Half-Life Monoclonal Antibody (mab) in Development for COVID-19 Prevention

Kathryn Mahoney,Deepali Gupta, Yong Li,Natalia Betancourt, Aanika Das,Ed Campanaro,Pete Schmidt

Open Forum Infectious Diseasesno. Supplement_2 (2023)

引用0浏览0引用

1113. Clinical and Virologic Outcomes with Early Adintrevimab (ADI) Monoclonal Antibody Therapy in Mild and Moderate COVID-19

Kathryn Mahoney,Kristin Narayan,Natalia Betancourt, Yong Li,Deepali Gupta,Pamela Hawn,Pete Schmidt,Myra Popejoy

Open forum infectious diseasesno. Supplement_2 (2022)

引用0浏览0引用

591. Adintrevimab (ADI) Population Pharmacokinetics (PPK) in Phase 1 and Phase 2/3 COVID-19 Prevention and Treatment Study Participants

Christopher M Rubino,Anthony P Cammarata,Paul Ambrose,Pete Schmidt,Myra Popejoy,Jean Gong,Xia Pu

Open Forum Infectious Diseasesno. Supplement_2 (2022)

引用0浏览0引用

226. Higher Doses of Adintrevimab, an Extended Half-Life Monoclonal Antibody, for the Treatment and Prevention of COVID-19: Preliminary Results from a Phase 1 Single Ascending-Dose Study

Xia Pu,Jean Gong,Ed Campanaro,Kristin Narayan,Deepali Gupta,Frank Engler, Amanda Copans,Pete Schmidt

Open forum infectious diseasesno. Supplement_2 (2022)

引用0浏览0引用

633. Preliminary Results from a Phase 1 Single Ascending-Dose Study Assessing Safety, Serum Viral Neutralizing Antibody Titers (svna), and Pharmacokinetic (PK) Profile of ADG20: an Extended Half-Life Monoclonal Antibody Being Developed for the Treatment and Prevention of Coronavirus Disease (COVID-19)

Helen Paguntalan,Zoltán Magyarics,Lynn E Connolly,Ellie Hershberger,Kristin Narayan,Deepali Gupta,Paul G Ambrose,Frank Engler,Ed Campanaro,Anita F Das,Pete Schmidt

Open forum infectious diseasesno. Supplement_1 (2021): S420-S420

引用2浏览0引用

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn